Wockhardt Ltd. is a prominent pharmaceutical company that engages in the development, manufacture, and distribution of pharmaceutical and biopharmaceutical formulations. Catering to global healthcare ... Wockhardt Ltd. is a prominent pharmaceutical company that engages in the development, manufacture, and distribution of pharmaceutical and biopharmaceutical formulations. Catering to global healthcare needs, it operates in segments such as generic drugs, biotechnology, and new chemical entities (NCEs). Wockhardt's primary focus is on improving patient health through innovative medications in therapeutic areas like cardiology, neurology, and infectious diseases. As a key player in the pharmaceutical industry, the company also emphasizes research-driven initiatives to address unmet medical needs. With facilities that are US FDA approved, Wockhardt exports its products to markets across the United States, Europe, and Asia, significantly contributing to global healthcare solutions while adhering to stringent quality standards and regulatory requirements.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Wockhardt is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Wockhardt is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Wockhardt's data?

Start your 30-day free trial to request a data review for Wockhardt.

Start Free Trial

Legal Center Contact Us